The relevance of CD2AP to memory dysfunction in AD is further substantiated by human data showing that the post-mortem levels of vascular CD2AP (but not total CD2AP) are lower in AD volunteers, particularly in male individuals, and such decrease is associated with poor cognitive performance, more specifically for the episodic and semantic memory [36]. This evidence concerns the gene CD2AP and Alzheimer disease.